Clinical Characteristic and Pathogen Spectrum of Neonatal Sepsis in Guangzhou City from June 2011 to June 2017

Junfei Guo, Yasha Luo, Yongbing Wu, Weiming Lai, Xiaoping Mu, Junfei Guo, Yasha Luo, Yongbing Wu, Weiming Lai, Xiaoping Mu

Abstract

BACKGROUND Preterm and low birth weight (birth weight <2500 g) neonates are vulnerable to sepsis, and the causative pathogens vary in different regions and times. The objective of this study was to identify common organisms leading to neonatal sepsis and identify the characteristic of patients infected with different bacteria, which may help in the selection of antibiotics for empirical treatment. MATERIAL AND METHODS We retrospectively collected the clinical and microbiological data of neonates with culture-proven sepsis in our clinical setting from June 2011 to June 2017. The demography, composition, and distribution of the pathogens and the clinical characteristic of the cases infected with different bacteria were analyzed. RESULTS Of a total of 1048 bacteria that were isolated from patient samples, detailed clinical and microbiological data of 297 cases were available. Escherichia coli, Klebsiella pneumoniae, and coagulase-negative Staphylococcus (co-NS) were the top 3 isolated pathogens. Streptococcus agalactiae predominantly led to early-onset sepsis, while K. pneumoniae and Staphylococcus aureus mainly led to late-onset sepsis. K. pneumoniae was mainly acquired in the hospital. Leukopenia was more commonly seen than leukocytosis in our study, and patients infected with K. pneumoniae and Candida spp encountered more thrombocytopenia. CONCLUSIONS The results of our study revealed the composition of the pathogens of neonatal sepsis in our region and the clinical characteristic of sepsis caused by different bacteria; these data may help in the selection of antibiotics for empirical treatment of neonates with high risk of sepsis.

Figures

Figure 1
Figure 1
The distribution of the pathogens. (A) The distribution of the pathogens from 2011 to June 2017 before exclusion of “false positive” of coagulase-negative Staphylococcus (co-NS). (B) The distribution of the pathogens with detail clinical and microbiological data after exclusion of “false positive” of co-NS.

References

    1. Wynn JL, Wong HR, Shanley TP, et al. Time for a neonatal-specific consensus definition for sepsis. Pediatric Crit Care Med. 2014;15:523–28.
    1. Paolucci M, Landini MP, Sambri V. How can the microbiologist help in diagnosing neonatal sepsis? Int J Pediatr. 2012;2012 120139.
    1. Qazi SA, Stoll BJ. Neonatal sepsis: A major global public health challenge. Pediatr Infect Dis J. 2009;28:S1–2.
    1. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: The burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127:817–26.
    1. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: A review of evidence from community-based studies. Pediatr Infect Dis J. 2009;28:S3–9.
    1. Al-Taiar A, Hammoud MS, Liu CQ, et al. Neonatal infections in China, Malaysia, Hong Kong and Thailand. Arch Dis Child-Fetal. 2013;98:F249–55.
    1. Van Den Hoogen A, Gerards LJ, Verboon-Maciolek MA, et al. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2010;97:22–28.
    1. Bizzarro MJ, Shabanova V, Baltimore RS, et al. Neonatal sepsis 2004–2013: The rise and fall of coagulase-negative staphylococci. J Pediatr. 2015;166:1193–99.
    1. Verani ML, Jr, Schrag SJ. Division of bacterial diseases NCfI, respiratory diseases CfDC, prevention. Prevention of Perinatal Group B Streptococcal Disease – revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:36.
    1. Ghotaslou R, Ghorashi Z, Nahaei MR. Klebsiella pneumoniae in neonatal sepsis: A 3-year-study in the pediatric hospital of Tabriz, Iran. Jpn J Infect Dis. 2007;60:126–28.
    1. Jiang YM, Kuang LH, Wang HJ, et al. The clinical characteristics of neonatal sepsis infection in southwest China. Internal Med. 2016;55:597–603.
    1. Vangay P, Ward T, Gerber JS, Knights D. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe. 2015;17:553–64.
    1. Zhou B, Liu X, Wu JB, et al. Clinical and microbiological profile of babies born with risk of neonatal sepsis. Exp Ther Med. 2016;12:3621–25.
    1. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006;117:67–74.
    1. Cordero L, Ayers LW. Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants. Infect Cont Hosp Ep. 2003;24:662–66.
    1. Tariq TM, Rasool E. Emerging trends of bloodstream infections: A six-year study at a paediatric tertiary care hospital in Kabul. Jcpsp-J Coll Physici. 2016;26:887–91.
    1. Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011;159:720–25.
    1. Gautam V, Sethuraman N, Kaur R, et al. Changing epidemiology of coagulase-negative staphylococci in normal flora of skin. Indian J Med Microbi. 2017;35:277–78.
    1. Zaidi AKM, Thaver D, Ali SA, Khan TA. Pathogens associated with sepsis in newborns and young infants in developing countries. Pediatr Infect Dis J. 2009;28:S10–18.
    1. Dong Y, Speer CP. The role of Staphylococcus epidermidis in neonatal sepsis: Guarding angel or pathogenic devil? Int J Med Microbiol. 2014;304:513–20.
    1. Jean-Baptiste N, Benjamin DK, Cohen-Wolkowiez M, et al. Coagulase-negative staphylococcal infections in the neonatal intensive care unit. Infect Cont Hosp Ep. 2011;32:679–86.
    1. Marchant EA, Boyce GK, Sadarangani M, Lavoie PM. Neonatal Sepsis due to coagulase-negative staphylococci. Clin Dev Immunol. 2013;5:586076.
    1. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr. 2011;159:392–97.
    1. Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011;159:720–25.
    1. Shane AL, Sanchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–80.
    1. Geyesus T, Moges F, Eshetie S, et al. Bacterial etiologic agents causing neonatal sepsis and associated risk factors in Gondar, Northwest Ethiopia. BMC Pediatrics. 2017;17:137.
    1. Jyothi P, Basavaraj MC, Basavaraj PV. Bacteriological profile of neonatal septicemia and antibiotic susceptibility pattern of the isolates. J Nat Sci Biol Med. 2013;4:306–9.
    1. Pammi M, Holland L, Butler G, et al. Candida parapsilosis is a significant neonatal pathogen: A systematic review and meta-analysis. Pediatr Infect Dis J. 2013;32:E206–16.
    1. Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: Epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126:E865–73.
    1. Sharma D, Farahbakhsh N, Shastri S, Sharma P. Biomarkers for diagnosis of neonatal sepsis: A literature review. J Matern Fetal Neonatal Med. 2018;31:1646–59.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi